Papers

Research literature with structured metadata.

Trials

Registered studies by status, phase, and compound.

Topics

Indications and themes psychedelics are researched for.

Compounds

Evidence across molecules with rich data.

Countries

Regulation, access, and research activity by region.

Stakeholders

Organizations shaping the space across research, policy, and funding.

People

Investigators, clinicians, and authors with mapped output.

Courses

Training programs and certifications across modalities.

Events

Conferences, workshops, and convenings by date and focus.

Results

Compare outcome data across trials and publications.

Research recaps

Monthly evidence summaries with key takeaways.

Map of research

Landscape view of trials, compounds, and outcomes.

Newsletter

Weekly or daily updates on trials, publications, analysis, and more.

Research Groups

Worldwide map of psychedelic research centres by region.

Road to Access

Science, regulation, and economics on the path to patient access.

Research Network

Interactive co-authorship map of psychedelic researchers.

Top papers

Find needles in the haystack of psychedelic research per topic.

Pricing
Back to journals
Academic Journal

Anesthesiology

2 Papers Indexed in Blossom

Published Papers

Paywallindividual

(R,S)-Ketamine metabolites (R,S)-norketamine and (2S,6S)-hydroxynorketamine increase the mammalian target of rapamycin function

This rodent study (2014) argues that a full analysis of (R,S)-ketamine's metabolites is required to understand ketamine's anti-depressive and analgesic effects.

Published
July 1, 2014
Journal
Anesthesiology
Authors
Paul, R. K., Singh, N. S., Khadeer, M., Sanghvi, M., Green, C. E., O'loughlin, K., Torjman, M. C., Bernier, M., Wainer, I. W.
Open Accessindividual

Psychedelic Effects of Ketamine in Healthy Volunteers: Relationship to Steady-state Plasma Concentrations

This crossover study of healthy volunteers (n=10) given computer-assisted continuous infusions, subanaesthetic ketamine (50–200 ng/ml steady-state plasma concentrations) produced dose-related psychedelic effects. Subjective ratings (VAS and the Hallucinogen Rating Scale) correlated highly linearly with venous ketamine concentrations (R ≈ 0.93–0.99 for VAS; overall plasma-target correlation R = 0.997) and yielded HRS scores comparable to those seen with DMT.

Published
January 1, 1998
Journal
Anesthesiology
Authors
Bowdle, A. T., Radant, A. D., Cowley, D. S., Kharasch, E. D., Strassman, R. J., Roy-Byrne, P. P.

Quick Facts

Papers Indexed
2
h-Index
277
Open Access
No
Publisher
Wolters Kluwer
Country
United States
Website
Visit

The intelligence layer for psychedelic research.

Company

  • About
  • Contact
  • Newsletter

Product

  • Feedback
  • Roadmap
  • Changelog
  • API
  • Partners

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.